Unlike 10 years ago, there is a public interest from both patients and practitioners surrounding adipose-derived stem cells. These stem cells are suitable for the treatment of diseases such as autoimmune illnesses, soft tissue defects and even ageing.1-3 Whilst we are still trying to understand this revolution in regenerative medicine, scientists and clinical researchers are already moving to the next stage, away from autologous stem cells to their messengers – exosomes.
Therefore, it is time for practitioners to understand this revolution in progress, moving us from traditional medicine to stem cell treatments and further to exosome research.
Back in 2001, the industry learnt that we could harvest stem cells from fat tissue.4 Since then, many different methods have been created to isolate our own stem cells and use them for different medical problems and diseases. Today, autologous…
